Garetosmab Demonstrates Sustained Efficacy in Adults With Fibrodysplasia Ossificans Progressiva @checkrare
Garetosmab Demonstrates Sustained Efficacy in Adults With Fibrodysplasia Ossificans Progressiva  @checkrare
Uploaded November 2026 | Updated November 2026, 4 hours ago
Richard Keen, MD, PhD, Director of the Metabolic Bone Disease Centre at the Royal National Orthopaedic Hospital in London and global principal investigator of the OPTIMA trial, discusses positive 84-week results from the phase 3 OPTIMA trial extension, evaluating Pasatru (garetosmab-grts) in adults with fibrodysplasia ossificans progressiva (FOP).

Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.

Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.

Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.

Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
Garetosmab Demonstrates Sustained Efficacy in Adults With Fibrodysplasia Ossificans ProgressivaApproval of Imaavy (Nipocalimab) and its Impact on Patients With Warm Autoimmune Hemolytic AnemiaGazyva Treatment: Steroid-Free Remission in Idiopathic Nephrotic SyndromeTherapies for MCT8 Deficiency and Nephrotic Syndrome Get FDA ApprovalUltragenyx Sells PRV for $210MCh 4: Treatment Gaps in C3GMaking Travel Accessible: SMAshing My Limits Partners With Becoming rentABLEResults From the Voice of PBC Patient SurveyUltragenyx Gets $203M in Second Priority Review Voucher This MonthPatient Perspective: Diagnosis and Treatment Journey With ROS1-Positive Non-Small Cell Lung CancerClinical Trials in Rare Endocrine Disorders | Rare Endocrine ExchangeTopline Results From the SANRECO Trial Testing Divesiran in Polycythemia Vera
CheckRare |

Garetosmab Demonstrates Sustained Efficacy in Adults With Fibrodysplasia Ossificans Progressiva

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER